Yahoo Web Search

Search results

  1. George W. Sledge Jr., M.D. is part of Stanford Profiles, official site for faculty, postdocs, students and staff information (Expertise, Bio, Research, Publications, and more). The site facilitates research and collaboration in academic endeavors.

  2. George W. Sledge Jr., M.D. Medical oncologist , Breast specialist. Adjunct Clinical Professor, Medicine - Oncology. Insurance Coverage Online Second Opinion Program Resources for Referring Physicians. Get In Touch. Make An Appointment. (650) 498-6000. Practice Locations. How to Message Your Care Team. Professional Summary.

  3. Dr. George W. Sledge, Jr. joined Caris Life Sciences in October 2022 and serves as Executive Vice President and Chief Medical Officer. In this role, Dr. Sledge oversees medical affairs, research, and medical education, including oversight and leadership for the Caris Precision Oncology Alliance™, and Caris’ global team of Medical Science ...

  4. Jun 30, 2024 · Breast cancer pioneer Dr. George W. Sledge, Jr., discusses current and future trends in treatment that utilize both biologics and more standard regimens.

  5. Ballve-Lantero Chair (Endowed Chair), Ballve-Lantero (1996) Editor-In-Chief, Clinical Breast Cancer (1999-present) Listed in "America's Top Doctors", Castle Connolly (2001-2012) Chair, Breast Committee, Eastern Cooperative Oncology Group (ECOG) (2002-2010)

  6. Oct 3, 2012 · George Sledge Jr., MD, will be the new chief of oncology in Stanford's Department of Medicine, effective Jan. 14, 2013. Sledge, a former president of the American Society for Clinical Oncology and a clinician-scientist focusing on innovative treatments for breast cancer, was recruited from the Indiana University Simon Cancer Center.

  7. George W. Sledge Jr. - Professor of Medicine (Oncology) Bio-X Affiliated Faculty. CAP Profile. Stanford Division of Oncology. Dr. Sledge's group is evaluating new means of examining circulating tumor cells in patients with breast cancer with the intent of improving therapy and reducing drug resistance.